+43-123-13-985|info@ces.b2sg.org
Loading Events
  • This event has passed.

The Department of Pharmacology at University of Maryland School of Medicine seeks an established, transcendent Cancer Biologist poised to have a transformative impact on cancer care to apply for the Drs. Angela and Harry Brodie Professorship in Translational Cancer Research at the level of Associate to Full Professor. We are especially interested in individuals with expertise in epigenetics and inflammation in cancer prevention/progression to expand our research programs in hormone responsive cancers. Successful research programs in these areas will strongly complement existing strengths within the department and the NCI Marlene and Stewart Greenebaum Cancer Center to present avenues of collaboration between both basic and translational researchers within the University of Maryland, School of Medicine.

 
Qualifications

 

Candidates should hold a Ph.D. and/or M.D. degree and have a strong history of scholarly activity.  Preference will be given to those with an independent funded research program and whose presence will catalyze multi-PI initiatives within the department. We offer an outstanding intellectual and collaborative environment with highly competitive salary and recruitment packages. All department faculty are members of the Graduate Program in Life Sciences which awards Ph.D. degrees in eight biomedical disciplines (http://lifesciences.umaryland.edu).
 
Candidates should provide the following information as one single PDF file: detailed Curriculum Vitae, a brief statement of research interests and goals, names and contact information for three references. For a full evaluation, candidates should submit their applications by January 15, 2018 (although applications will be accepted until the position is filled).
 
All applications should be submitted through Taleo, addressed to the attention of Dr. Margaret McCarthy.
 
The University of Maryland, Baltimore is an Equal Opportunity/Affirmative Action employer. Minorities, women, protected veterans and individuals with disabilities are encouraged to apply.